El 212 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from El 212. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In El 212 Today - Breaking & Trending Today

Sobi, Selecta: Phase 3 DISSOLVE Program Of SEL-212 In Chronic Refractory Gout Meets Primary Goal

Published: March 22, 2023

Swedish Orphan Biovitrum AB or Sobi (SWTUY.PK), a specialised biopharmaceutical company, and Selecta Biosciences, Inc. (SELB) announced Tuesday positive topline results from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout.

Source: rttnews.com

Related Topics:

Selecta BiosciencesSelecta ImmSelecta Biosciences IncMore Such Health NewsSwedish Orphan BiovitrumChronic RefractoryGlobal StudySelecta BiosciencesChronic Refractory GoutHase 3 Dissolve ProgramIssolve ProgramEl 212